Log in to save to my catalogue

Intravenous BCG vaccination in non-human primates induces superior serum antibody titers with enhanc...

Intravenous BCG vaccination in non-human primates induces superior serum antibody titers with enhanc...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11906387

Intravenous BCG vaccination in non-human primates induces superior serum antibody titers with enhanced avidity and opsonizing capacity compared to the intradermal route

About this item

Full title

Intravenous BCG vaccination in non-human primates induces superior serum antibody titers with enhanced avidity and opsonizing capacity compared to the intradermal route

Publisher

Netherlands: Elsevier Ltd

Journal title

Vaccine, 2024-12, Vol.42 (26), p.126444-126444, Article 126444

Language

English

Formats

Publication information

Publisher

Netherlands: Elsevier Ltd

More information

Scope and Contents

Contents

AbstractA new and more effective tuberculosis (TB) vaccine is urgently needed, but development is hampered by the lack of validated immune correlates of protection. Bacillus Calmette Guérin (BCG) vaccination by the aerosol (AE) and intravenous (IV) routes has been shown to confer superior levels of protection from challenge with Mycobacterium tuber...

Alternative Titles

Full title

Intravenous BCG vaccination in non-human primates induces superior serum antibody titers with enhanced avidity and opsonizing capacity compared to the intradermal route

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11906387

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11906387

Other Identifiers

ISSN

0264-410X,1873-2518

E-ISSN

1873-2518

DOI

10.1016/j.vaccine.2024.126444

How to access this item